Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anaphylactic Shock, Antibodies, Anticoagulant, Atrial Fibrillation, Blood, Clinical Trial, Constipation, CT, Delirium, Dronedarone, Drugs, Emergency Medicine, Evolution, Headache, heart, Heart Disease, Hemoglobin, Heparin, Hospital, Hypersensitivity, Hypoglycemia, Hypokalemia, Hypotension, Nursing, Pneumonia, Pregnancy, Prophylaxis, Prosthetic, Protamine, Pulmonary Embolism, Stroke, Thrombocytopenia, Thrombosis, Uric Acid, Valvular Heart Disease, Veterinary, Vitamin, Vitamin K, Warfarin